Skip to main content
Clinical Trials/NL-OMON50052
NL-OMON50052
Completed
Not Applicable

Pharmacokinetic and pharmacodynamic target attainment of ceftazidime in adult patients on general wards with different degrees of renal function: a prospective observational cohort study - Target attainment of ceftazidime

Academisch Medisch Centrum0 sites40 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Infections
Sponsor
Academisch Medisch Centrum
Enrollment
40
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • Receiving ceftazidime therapy intravenous (iv) as part of standard care
  • Age \* 18 years
  • Admitted to a general ward of Amsterdam UMC \- location AMC or Noordwest
  • Ziekenhuisgroep location Alkmaar
  • Informed consent is obtained

Exclusion Criteria

  • Mentally incapacitated patients , i.e. a minor or legally incompetent adult
  • Renal replacement therapy during treatment with ceftazidime
  • Patients admitted to the intensive care unit (ICU)
  • Severely burned patients, defined as a burned surface \* 10%
  • Patients with cystic fibrosis
  • Informed consent is not obtained

Outcomes

Primary Outcomes

Not specified

Similar Trials